H.R. 3789 · Where this bill is now
In committee
Introduced in the House, sent to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned, Jun 5, 2025
What this bill does
In plain words · AI-written from the official summaryDrug ads must show prices for consumers
When pharmaceutical companies advertise prescription drugs or biological products (like vaccines or injections made from living cells), they would have to display the wholesale price for a 30-day supply in their ads. The rule only applies to drugs covered by Medicare or Medicaid that already include safety information in their advertising. Ads for drugs costing less than $35 for a month's supply wouldn't need to show the price. Companies that violate this requirement could face penalties up to $100,000 per violation.
How it affects you
If you watch TV, listen to radio, or see ads online, you'd see drug prices displayed more openly when pharmaceutical companies advertise medications. This lets you see the wholesale cost upfront, though you'd likely pay a different amount depending on your specific insurance plan. The ads can also explain that your actual price might vary based on your coverage.
Read the official summary (Introduced in House, Jun 5, 2025)
Drug-price Transparency for Consumers Act of 2025 or the DTC Act of 2025
This bill requires consumer advertisements for prescription drugs and biological products to include certain price information if the drug or biologic is (1) covered under Medicare or Medicaid, and (2) required to include a risk summary under current law.
Specifically, such advertisements must clearly and conspicuously disclose the wholesale price for a 30-day supply of the drug or biologic and may explain that a consumer may pay a different amount for the drug or biologic depending on the consumer's health insurance coverage.
The requirement does not apply to advertisements for drugs or biologics with a wholesale cost of less than $35 for a one-month supply.
Each violation of this requirement is subject to a civil penalty of not more than $100,000.
Written by AI (Claude) using only the official summary by the Congressional Research Service, the Library of Congress’s nonpartisan research staff. It can miss nuance, so check the official summary and the bill text for details.
1st SessionH. R. 3789
A BILL
DTC Act of 2025
Sponsor: Rep. David J. Taylor (R-OH-2) · Introduced Jun 5, 2025 · Health · 1 version of the text
Sources: Congress.gov actions and votes · bill text from GovInfo · latest official action Jun 5, 2025: “Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.”